Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 10,390
-140 (-1.33%)
Apr 2, 2026, 3:30 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 192.05 billion as of April 2, 2026. Its market cap has increased by 9.58% in one year.
Market Cap
192.05B
Enterprise Value
129.01B
Revenue
255.21B
Ranking
n/a
PE Ratio
12.12
Stock Price
10,390.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 192.05B, an increase of 274.95%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 194.64B | 12.62% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 222.85B |
| Ilyang Pharmaceutical Co.,Ltd | 217.25B |
| Samil Pharmaceutical Co.,Ltd | 208.05B |
| Suheung | 207.80B |
| JW Lifescience | 205.02B |
| AptaBio Therapeutics | 204.24B |
| Kyongbo Pharmaceutical | 200.82B |
| Jeil Pharmaceutical Co.,Ltd | 199.34B |